| P50 | author | Sarah Gilbert | Q30513802 |
| | Elma Z Tchilian | Q46991209 |
| | Sharon M Brookes | Q56847574 |
| | Helen E Everett | Q103835914 |
| P2093 | author name string | Sophie Morgan | |
| | Mark E J Woolhouse | |
| | Ian H Brown | |
| | Laetitia Canini | |
| | Andrew Ramsay | |
| | Michael Kelly | |
| | Bryan Charleston | |
| | Mario Aramouni | |
| | Vivien Coward | |
| P2860 | cites work | Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigs | Q27334919 |
| | Control of a Reassortant Pandemic 2009 H1N1 Influenza Virus Outbreak in an Intensive Swine Breeding Farm: Effect of Vaccination and Enhanced Farm Management Practices. | Q30374307 |
| | Molecular Epidemiology and Evolution of Influenza Viruses Circulating within European Swine between 2009 and 2013 | Q30377049 |
| | Serologic cross-reactivity with pandemic (H1N1) 2009 virus in pigs, Europe. | Q30383853 |
| | Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs. | Q30385384 |
| | Development and evaluation of a one-step real-time RT-PCR assay for universal detection of influenza A viruses from avian and mammal species. | Q30386666 |
| | The global antigenic diversity of swine influenza A viruses | Q30387317 |
| | Distinct immune responses and virus shedding in pigs following aerosol, intra-nasal and contact infection with pandemic swine influenza A virus, A(H1N1)09 | Q30394336 |
| | Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines. | Q30403668 |
| | Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus | Q30414781 |
| | Evolution of an Eurasian avian-like influenza virus in naïve and vaccinated pigs | Q30417920 |
| | Proteome-wide screening reveals immunodominance in the CD8 T cell response against classical swine fever virus with antigen-specificity dependent on MHC class I haplotype expression | Q31146808 |
| | Swine influenza virus vaccines: to change or not to change-that's the question | Q38043369 |
| | Influenza A virus vaccines for swine | Q38786494 |
| | Hemagglutinin inhibition assay with swine sera | Q42214420 |
| | Swine influenza A vaccines, pandemic (H1N1) 2009 virus, and cross-reactivity | Q42725696 |
| | Principles of selective inactivation of viral genome. VI. Inactivation of the infectivity of the influenza virus by the action of beta-propiolactone | Q45854459 |
| | The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease | Q59353304 |
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pandemic | Q12184 |
| | infectious disease | Q18123741 |
| | swine influenza | Q36855 |
| | influenza A virus | Q834390 |
| | H1N1 | Q5628785 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 2288-2293 | |
| P577 | publication date | 2019-03-23 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Vaccine-mediated protection of pigs against infection with pandemic H1N1 2009 swine influenza A virus requires a close antigenic match between the vaccine antigen and challenge virus | |
| P478 | volume | 37 | |